A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of Southern California
- Study ID
- NCT06336928
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study evaluates whether a special type of blood analysis, called liquid biopsy (LBx), correlates with mammography results and/or diagnosis of breast cancer.
Key Dates
- Start date
- Jun 7, 2024
- Status verified
- Mar 2026
- Primary completion
- Jun 7, 2029
- Completion
- Jun 7, 2030
Study Design
- Enrollment
- 490 participants (estimated)
Arms
- Arm: ObservationalPatients undergo blood sample collection and have their medical records reviewed on study.
Primary Outcome Measure
Assess the sensitivity and specificity of LBx as a screening method for breast cancer [ Time Frame: Up to 1 year ]
Central Contacts
- Kimberly Arieli, RN323-865-0451
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Keck Medicine of USC Koreatown | Los Angeles | California | 90020 | Anastasia Martynova, MD (PRINCIPAL_INVESTIGATOR) |
| Los Angeles General Medical Center | Los Angeles | California | 90033 | Anastasia Martynova, MD (PRINCIPAL_INVESTIGATOR) |
| USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Anastasia Martynova, MD (PRINCIPAL_INVESTIGATOR) |
| USC Norris Oncology/Hematology-Newport Beach | Newport Beach | California | 92663 | Anastasia Martynova, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
By condition
By specialty
Related Studies
- Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast CancerRecruiting · City of Hope Medical Center · Duarte, California
- Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast CancerPHASE2 · Recruiting · National Cancer Institute (NCI) · Duarte, California
- Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible ParticipantsRecruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- Mobile Health for Adherence in Breast Cancer PatientsRecruiting · ECOG-ACRIN Cancer Research Group · Fairbanks, Alaska